Bank of America’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $539K | Sell |
37,177
-11,124
| -23% | -$129K | ﹤0.01% | 4856 |
|
|
2025
Q4 | $464K | Buy |
48,301
+18,619
| +63% | +$178K | ﹤0.01% | 4948 |
|
|
2025
Q3 | $279K | Sell |
29,682
-1,180
| -4% | -$11.3K | ﹤0.01% | 6115 |
|
|
2025
Q2 | $327K | Sell |
30,862
-2,269
| -7% | -$28.6K | ﹤0.01% | 5942 |
|
|
2025
Q1 | $498K | Sell |
33,131
-5,087
| -13% | -$84.6K | ﹤0.01% | 5652 |
|
|
2024
Q4 | $629K | Buy |
38,218
+3,758
| +11% | +$74.1K | ﹤0.01% | 5377 |
|
|
2024
Q3 | $851K | Sell |
34,460
-2,193
| -6% | -$56.9K | ﹤0.01% | 5161 |
|
|
2024
Q2 | $928K | Sell |
36,653
-266
| -0.7% | -$6.89K | ﹤0.01% | 4946 |
|
|
2024
Q1 | $938K | Sell |
36,919
-19,254
| -34% | -$466K | ﹤0.01% | 4969 |
|
|
2023
Q4 | $1.27M | Sell |
56,173
-18,658
| -25% | -$386K | ﹤0.01% | 4802 |
|
|
2023
Q3 | $1.39M | Buy |
74,831
+19,186
| +34% | +$398K | ﹤0.01% | 4564 |
|
|
2023
Q2 | $1.45M | Sell |
55,645
-2,676
| -5% | -$71.6K | ﹤0.01% | 4495 |
|
|
2023
Q1 | $1.67M | Buy |
58,321
+9,854
| +20% | +$293K | ﹤0.01% | 4504 |
|
|
2022
Q4 | $1.43M | Buy |
48,467
+7,524
| +18% | +$214K | ﹤0.01% | 4550 |
|
|
2022
Q3 | $975K | Buy |
40,943
+16,193
| +65% | +$373K | ﹤0.01% | 4920 |
|
|
2022
Q2 | $553K | Sell |
24,750
-3,207
| -11% | -$71.5K | ﹤0.01% | 5370 |
|
|
2022
Q1 | $702K | Sell |
27,957
-17,521
| -39% | -$534K | ﹤0.01% | 5551 |
|
|
2021
Q4 | $1.63M | Buy |
45,478
+27,049
| +147% | +$1.08M | ﹤0.01% | 4765 |
|
|
2021
Q3 | $784K | Sell |
18,429
-239
| -1% | -$9.84K | ﹤0.01% | 5288 |
|
|
2021
Q2 | $809K | Sell |
18,668
-19,292
| -51% | -$822K | ﹤0.01% | 5062 |
|
|
2021
Q1 | $1.55M | Buy |
37,960
+25,163
| +197% | +$954K | ﹤0.01% | 4471 |
|
|
2020
Q4 | $579K | Sell |
12,797
-11,480
| -47% | -$436K | ﹤0.01% | 4910 |
|
|
2020
Q3 | $859K | Buy |
24,277
+4,564
| +23% | +$165K | ﹤0.01% | 4329 |
|
|
2020
Q2 | $744K | Buy |
19,713
+2,925
| +17% | +$96.4K | ﹤0.01% | 4336 |
|
|
2020
Q1 | $485K | Buy |
16,788
+7,577
| +82% | +$306K | ﹤0.01% | 4518 |
|
|
2019
Q4 | $478K | Sell |
9,211
-6,906
| -43% | -$401K | ﹤0.01% | 5034 |
|
|
2019
Q3 | $884K | Sell |
16,117
-9,509
| -37% | -$488K | ﹤0.01% | 4640 |
|
|
2019
Q2 | $1.04M | Sell |
25,626
-13,479
| -34% | -$491K | ﹤0.01% | 4538 |
|
|
2019
Q1 | $1.18M | Buy |
39,105
+18,579
| +91% | +$636K | ﹤0.01% | 4392 |
|
|
2018
Q4 | $690K | Buy |
20,526
+14,082
| +219% | +$508K | ﹤0.01% | 4701 |
|
|
2018
Q3 | $272K | Buy |
6,444
+1,520
| +31% | +$60.1K | ﹤0.01% | 5313 |
|
|
2018
Q2 | $157K | Sell |
4,924
-1,801
| -27% | -$74.2K | ﹤0.01% | 5549 |
|
|
2018
Q1 | $335K | Sell |
6,725
-5,993
| -47% | -$339K | ﹤0.01% | 5079 |
|
|
2017
Q4 | $686K | Sell |
12,718
-5,243
| -29% | -$290K | ﹤0.01% | 4730 |
|
|
2017
Q3 | $1.04M | Sell |
17,961
-2,257
| -11% | -$118K | ﹤0.01% | 4479 |
|
|
2017
Q2 | $997K | Sell |
20,218
-3,077
| -13% | -$142K | ﹤0.01% | 4432 |
|
|
2017
Q1 | $1.01M | Buy |
23,295
+11,511
| +98% | +$550K | ﹤0.01% | 4419 |
|
|
2016
Q4 | $577K | Buy |
11,784
+10,729
| +1,017% | +$496K | ﹤0.01% | 4720 |
|
|
2016
Q3 | $51K | Sell |
1,055
-141
| -12% | -$6.96K | ﹤0.01% | 5723 |
|
|
2016
Q2 | $64K | Sell |
1,196
-2,314
| -66% | -$109K | ﹤0.01% | 5727 |
|
|
2016
Q1 | $157K | Sell |
3,510
-209
| -6% | -$8.48K | ﹤0.01% | 5269 |
|
|
2015
Q4 | $142K | Sell |
3,719
-3,246
| -47% | -$124K | ﹤0.01% | 5571 |
|
|
2015
Q3 | $222K | Sell |
6,965
-8,654
| -55% | -$302K | ﹤0.01% | 5278 |
|
|
2015
Q2 | $516K | Buy |
15,619
+11,538
| +283% | +$412K | ﹤0.01% | 4675 |
|
|
2015
Q1 | $168K | Sell |
4,081
-5,738
| -58% | -$232K | ﹤0.01% | 5038 |
|
|
2014
Q4 | $400K | Buy |
9,819
+6,882
| +234% | +$269K | ﹤0.01% | 4822 |
|
|
2014
Q3 | $108K | Buy |
2,937
+2,530
| +622% | +$109K | ﹤0.01% | 5942 |
|
|
2014
Q2 | $19K | Sell |
407
-6,668
| -94% | -$297K | ﹤0.01% | 7177 |
|
|
2014
Q1 | $291K | Sell |
7,075
-4,880
| -41% | -$181K | ﹤0.01% | 5100 |
|
|
2013
Q4 | $456K | Buy |
11,955
+10,284
| +615% | +$317K | ﹤0.01% | 4843 |
|
|
2013
Q3 | $40K | Buy |
1,671
+449
| +37% | +$10.1K | ﹤0.01% | 6542 |
|
|
2013
Q2 | $21K | Buy |
+1,222
| New | +$17.6K | ﹤0.01% | 6934 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Bank of America's ANIK Position: Q1 2026 in Review
Bank of America reduced its Anika Therapeutics (ANIK) stake by 23% in Q1 2026, selling an estimated $129K and leaving 37,177 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #4856.
Bank of America first reported a position in ANIK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.67M in Q1 2023. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Bank of America held 37,177 shares of Anika Therapeutics worth $539K as of Q1 2026.
- Bank of America sold 11,124 Anika Therapeutics shares in Q1 2026, an estimated $129K.
- Anika Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4856 holding.
- Bank of America first reported a position in Anika Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Anika Therapeutics position peaked at $1.67M in Q1 2023.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.